X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1094) 1094
Publication (109) 109
Newsletter (46) 46
Book Review (14) 14
Book Chapter (12) 12
Newspaper Article (9) 9
Magazine Article (6) 6
Conference Proceeding (2) 2
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
valganciclovir (917) 917
humans (687) 687
index medicus (586) 586
cytomegalovirus (499) 499
transplantation (491) 491
ganciclovir (432) 432
male (376) 376
antiviral agents - therapeutic use (361) 361
female (357) 357
ganciclovir - analogs & derivatives (337) 337
cytomegalovirus infections (335) 335
disease (310) 310
infection (301) 301
middle aged (300) 300
adult (295) 295
cytomegalovirus infections - prevention & control (281) 281
ganciclovir - therapeutic use (278) 278
prophylaxis (247) 247
surgery (240) 240
prevention (239) 239
cytomegalovirus infections - drug therapy (232) 232
immunology (232) 232
organ transplant recipients (221) 221
health aspects (207) 207
infectious diseases (206) 206
virus diseases (180) 180
risk factors (178) 178
recipients (177) 177
oral ganciclovir (171) 171
antiviral agents - administration & dosage (163) 163
ganciclovir - administration & dosage (163) 163
treatment outcome (157) 157
retrospective studies (139) 139
cytomegalovirus infections - virology (133) 133
preemptive therapy (132) 132
kidneys (129) 129
pharmacology & pharmacy (129) 129
aged (128) 128
kidney transplantation (125) 125
therapy (119) 119
drug therapy (118) 118
valganciclovir prophylaxis (118) 118
transplantation of organs, tissues, etc (116) 116
efficacy (115) 115
antiviral agents (109) 109
pediatrics (106) 106
infections (101) 101
kidney transplantation - adverse effects (100) 100
management (100) 100
cytomegalovirus infections - diagnosis (99) 99
cytomegalovirus infections - epidemiology (99) 99
cytomegalovirus - drug effects (98) 98
analysis (96) 96
viral load (95) 95
oral valganciclovir (92) 92
adolescent (89) 89
cytomegalovirus infections - etiology (89) 89
cytomegalovirus - isolation & purification (87) 87
transplants & implants (86) 86
virology (84) 84
research (83) 83
solid-organ transplantation (82) 82
pharmacokinetics (81) 81
intravenous ganciclovir (80) 80
renal-transplantation (80) 80
cytomegalovirus - genetics (79) 79
administration, oral (78) 78
children (78) 78
time factors (78) 78
antiviral agents - adverse effects (76) 76
cmv infection (76) 76
medical research (76) 76
cmv (75) 75
microbiology (75) 75
risk (74) 74
safety (74) 74
care and treatment (73) 73
incidence (73) 73
child (72) 72
medicine, experimental (72) 72
dosage and administration (71) 71
impact (66) 66
mortality (66) 66
cytomegalovirus infections - immunology (65) 65
ganciclovir - adverse effects (65) 65
antiviral agents - pharmacology (64) 64
follow-up studies (64) 64
immunosuppressive agents - therapeutic use (64) 64
young adult (64) 64
cmv disease (63) 63
lung transplantation (63) 63
cytomegalovirus disease (62) 62
transplant recipients (62) 62
infant, newborn (60) 60
organ transplantation - adverse effects (58) 58
polymerase chain reaction (58) 58
complications and side effects (57) 57
cytomegalovirus infections - complications (57) 57
infant (57) 57
diagnosis (56) 56
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1114) 1114
Spanish (20) 20
French (10) 10
German (5) 5
Czech (4) 4
Polish (3) 3
Italian (2) 2
Korean (2) 2
Russian (2) 2
Hungarian (1) 1
Japanese (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Laryngoscope, ISSN 0023-852X, 2019
To determine whether ganciclovir (GCV) treatment reduces sensorineural hearing loss in cytomegalovirus (CMV)-infected mice. The effects of GCV on viral load,... 
valganciclovir | Cytomegalovirus | mouse | ganciclovir | hearing loss
Journal Article
Hematological Oncology, ISSN 0278-0232, 06/2019, Volume 37, Issue S2, p. 335
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 10, pp. 933 - 943
Journal Article
Journal Article
Journal Article
Reviews in Medical Virology, ISSN 1052-9276, 11/2018, Volume 28, Issue 6, pp. e2015 - n/a
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 02/2019, Volume 38, Issue 2, pp. 127 - 130
BACKGROUND:Valganciclovir (2/d) therapy for 6 months in neonates with symptomatic congenital cytomegalovirus (cCMV) infection improves hearing and... 
HEARING-LOSS | INFECTIOUS DISEASES | cytomegalovirus | congenital cytomegalovirus | LENTICULOSTRIATED VASCULOPATHY | INFANTS | valganciclovir | PEDIATRICS | IMMUNOLOGY | ORAL VALGANCICLOVIR | Hematologic agents | Cytomegalovirus infections | Health aspects
Journal Article
Transplantation Direct, ISSN 0041-1337, 08/2019, Volume 103, Issue 8, pp. 1730 - 1735
BACKGROUND.Valganciclovir has been widely used for cytomegalovirus (CMV) prophylaxis in solid-organ transplant recipients. However, the optimal dosing protocol... 
SURGERY | AREA | DISEASE | GANCICLOVIR | PREVENTION | INFECTION | IMMUNOLOGY | PHARMACOKINETIC PROFILE | ORAL VALGANCICLOVIR | TRANSPLANTATION
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 04/2019, Volume 38, Issue 4, pp. S397 - S397
Women comprise 1 in 4 of all heart transplant (HT) recipients. Sex/gender differences affect cardiovascular disease burden and outcomes with important... 
Heart | Evaluation | Transplantation | Valganciclovir | Blood cell count | Immunotherapy
Journal Article
Pediatric Infectious Disease Journal, ISSN 0891-3668, 08/2017, Volume 36, Issue 8, pp. 745 - 750
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 09/2017, Volume 17, Issue 9, pp. 2468 - 2473
Journal Article